AZTA Azenta Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AZTA

Price (delayed)

$33.38

Market cap

$1.46B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.67

Enterprise value

$1.32B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 25

Brooks operates two global, market-leading businesses, Life Sciences and Semiconductor Solutions, each with its own distinct area of focus and expertise. The Life Sciences business, to be operated under the ...

Highlights
Azenta's revenue has increased by 4.8% YoY and by 2.9% from the previous quarter
AZTA's gross profit is up by 2.3% since the previous quarter
The EPS has grown by 29% from the previous quarter but it has contracted by 5% YoY
The company's net income rose by 29% QoQ but it fell by 9% YoY
Azenta's quick ratio has decreased by 14% QoQ and by 4.9% YoY
AZTA's equity is down by 10% year-on-year and by 2.9% since the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.brooks.com

Key stats

What are the main financial stats of AZTA

AZTA stock price

How has the Azenta stock price performed over time
Intraday
-1.56%
1 week
4.18%
1 month
31.21%
1 year
9.12%
YTD
0.36%
QTD
30.8%

Financial performance

How have Azenta's revenue and profit performed over time
Revenue
$613.57M
Gross profit
$266.06M
Operating income
-$175.83M
Net income
-$122.94M
Gross margin
43.4%
Net margin
-20%
AZTA's net margin is up by 31% since the previous quarter but it is down by 4.2% year-on-year
The company's net income rose by 29% QoQ but it fell by 9% YoY
Azenta's revenue has increased by 4.8% YoY and by 2.9% from the previous quarter
Azenta's gross margin has decreased by 4% YoY

Price vs fundamentals

How does AZTA's price correlate with its fundamentals

Growth

What is Azenta's growth rate over time

Valuation

What is Azenta stock price valuation
AZTA P/E details
P/E
N/A
P/B
1.02
P/S
2.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.16
The EPS has grown by 29% from the previous quarter but it has contracted by 5% YoY
AZTA's P/B is 40% below its 5-year quarterly average of 1.7 but 28% above its last 4 quarters average of 0.8
AZTA's equity is down by 10% year-on-year and by 2.9% since the previous quarter
The stock's price to sales (P/S) is 59% less than its 5-year quarterly average of 6.0 but 17% more than its last 4 quarters average of 2.1
Azenta's revenue has increased by 4.8% YoY and by 2.9% from the previous quarter

Efficiency

How efficient is Azenta business performance
Azenta's return on invested capital has shrunk by 68% YoY but it has increased by 26% QoQ
The ROS has plunged by 61% YoY but it has grown by 26% from the previous quarter
Azenta's ROA has increased by 28% from the previous quarter but it has decreased by 13% YoY
Azenta's return on equity has increased by 27% QoQ but it has decreased by 17% YoY

Dividends

What is AZTA's dividend history
Dividend details
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Azenta financials performed over time
Azenta's quick ratio has decreased by 14% QoQ and by 4.9% YoY
AZTA's current ratio is down by 12% since the previous quarter and by 9% year-on-year
AZTA's debt is 96% smaller than its equity
AZTA's debt to equity is up by 33% year-on-year
AZTA's equity is down by 10% year-on-year and by 2.9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.